Affinity Asset Advisors, LLC - NLS PHARMACEUTICS LTD ownership

Back to all holdings Add to watchlist

NLS PHARMACEUTICS LTD's ticker is NLSP and the CUSIP is H57830103. A total of 8 filers reported holding NLS PHARMACEUTICS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Affinity Asset Advisors, LLC ownership history of NLS PHARMACEUTICS LTD
ValueSharesWeighting
Q3 2023$140,319
-68.1%
200,455
-49.9%
0.04%
-74.7%
Q2 2023$440,000
-15.3%
400,000
+16.2%
0.15%
-9.9%
Q1 2023$519,574–344,089–0.17%–
 Download
Other shareholders
NLS PHARMACEUTICS LTD shareholders Q1 2023
NameSharesValueWeighting ↓
BVF INC/IL 5,747,126$3,970,6890.11%
Affinity Asset Advisors, LLC 200,455$140,3190.04%
J. Goldman & Co LP 254,601$178,2210.01%
BANK OF AMERICA CORP /DE/ 90$630.00%
WELLS FARGO & COMPANY/MN 56,549$39,5840.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 14,362$9,9220.00%
Renaissance Technologies 21,100$150.00%
View complete list of NLS PHARMACEUTICS LTD shareholders